REPORTS

Let’s Pullulate and Expand Your Business

Global Spinal Muscular Atrophy Medicine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jun 19, 2020  |  198 PAGES  |  REPORT CODE: CMM309713
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Spinal Muscular Atrophy Medicine is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period. The research provides insights for the global Spinal Muscular Atrophy Medicine market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Spinal Muscular Atrophy Medicine industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Spinal Muscular Atrophy Medicine Market Segmentations:

By Players:

  • Astellas Pharma Inc

  • AveXis, Inc

  • Bioblast Pharma Ltd

  • Cytokinetics, Inc 24

  • F Hoffmann-La Roche Ltd

  • Genethon

  • Genzyme Corporation

  • GMP-Orphan SAS

  • Ionis Pharmaceuticals, Inc

  • Longevity Biotech, Inc

  • Neurodyn Inc

  • Neurotune AG

  • Novartis AG

  • Sarepta Therapeutics, Inc

  • Voyager Therapeutics, Inc

  • Vybion, Inc

  • WAVE Life Sciences Ltd

By Types:

  • LMI-070

  • ND-602

  • NT-1654

  • Nusinersen

  • NXD-30001

  • Others

By End-User:

  • Hospital

  • Clinic

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Spinal Muscular Atrophy Medicine Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of LMI-070 from 2014 to 2026

    • 1.3.2 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of ND-602 from 2014 to 2026

    • 1.3.3 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NT-1654 from 2014 to 2026

    • 1.3.4 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Nusinersen from 2014 to 2026

    • 1.3.5 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NXD-30001 from 2014 to 2026

    • 1.3.6 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Spinal Muscular Atrophy Medicine Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Spinal Muscular Atrophy Medicine Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Spinal Muscular Atrophy Medicine by Major Types

    • 3.4.1 Spinal Muscular Atrophy Medicine Market Size and Growth Rate of LMI-070

    • 3.4.2 Spinal Muscular Atrophy Medicine Market Size and Growth Rate of ND-602

    • 3.4.3 Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NT-1654

    • 3.4.4 Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Nusinersen

    • 3.4.5 Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NXD-30001

    • 3.4.6 Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Others

4 Segmentation of Spinal Muscular Atrophy Medicine Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Spinal Muscular Atrophy Medicine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Spinal Muscular Atrophy Medicine in Hospital

    • 4.4.2 Market Size and Growth Rate of Spinal Muscular Atrophy Medicine in Clinic

    • 4.4.3 Market Size and Growth Rate of Spinal Muscular Atrophy Medicine in Others

5 Market Analysis by Major Regions

  • 5.1 Global Spinal Muscular Atrophy Medicine Production Analysis by Major Regions

  • 5.2 Global Spinal Muscular Atrophy Medicine Consumption Analysis by Major Regions

  • 5.3 Global Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis

6 Product Commodity of Spinal Muscular Atrophy Medicine Market in Major Countries

  • 6.1 Top 5 Export Countries in Spinal Muscular Atrophy Medicine market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Spinal Muscular Atrophy Medicine market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Spinal Muscular Atrophy Medicine Landscape Analysis

  • 7.1 North America Spinal Muscular Atrophy Medicine Landscape Analysis by Major Types

  • 7.2 North America Spinal Muscular Atrophy Medicine Landscape Analysis by Major End-Users

  • 7.3 North America Spinal Muscular Atrophy Medicine Landscape Analysis by Major Countries

    • 7.3.1 United States Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 7.3.2 Canada Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 7.3.3 Mexico Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

8 Europe Spinal Muscular Atrophy Medicine Landscape Analysis

  • 8.1 Europe Spinal Muscular Atrophy Medicine Landscape Analysis by Major Types

  • 8.2 Europe Spinal Muscular Atrophy Medicine Landscape Analysis by Major End-Users

  • 8.3 Europe Spinal Muscular Atrophy Medicine Landscape Analysis by Major Countries

    • 8.3.1 Germany Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.2 UK Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.3 France Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.4 Italy Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.6 Spain Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.7 Belgium Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.8 Poland Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.9 Russia Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 8.3.10 Turkey Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

9 Asia Pacific Spinal Muscular Atrophy Medicine Landscape Analysis

  • 9.1 Asia Pacific Spinal Muscular Atrophy Medicine Landscape Analysis by Major Types

  • 9.2 Asia Pacific Spinal Muscular Atrophy Medicine Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Spinal Muscular Atrophy Medicine Landscape Analysis by Major Countries

    • 9.3.1 China Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 9.3.2 Japan Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 9.3.4 India Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 9.3.6 South Korea Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

10 Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 10.3.2 Brazil Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 10.3.3 Nigeria Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

    • 10.3.4 South Africa Spinal Muscular Atrophy Medicine Market Volume and Growth Rate 

    • 10.3.5 Argentina Spinal Muscular Atrophy Medicine Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Astellas Pharma Inc

    • 11.1.1 Astellas Pharma Inc Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 AveXis, Inc

    • 11.2.1 AveXis, Inc Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Bioblast Pharma Ltd

    • 11.3.1 Bioblast Pharma Ltd Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Cytokinetics, Inc 24

    • 11.4.1 Cytokinetics, Inc 24 Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 F Hoffmann-La Roche Ltd

    • 11.5.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Genethon

    • 11.6.1 Genethon Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Genzyme Corporation

    • 11.7.1 Genzyme Corporation Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 GMP-Orphan SAS

    • 11.8.1 GMP-Orphan SAS Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Ionis Pharmaceuticals, Inc

    • 11.9.1 Ionis Pharmaceuticals, Inc Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Longevity Biotech, Inc

    • 11.10.1 Longevity Biotech, Inc Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Neurodyn Inc

    • 11.11.1 Neurodyn Inc Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Neurotune AG

    • 11.12.1 Neurotune AG Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Novartis AG

    • 11.13.1 Novartis AG Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Sarepta Therapeutics, Inc

    • 11.14.1 Sarepta Therapeutics, Inc Company Profile and Recent Development

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Voyager Therapeutics, Inc

    • 11.15.1 Voyager Therapeutics, Inc Company Profile and Recent Development

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Vybion, Inc

    • 11.16.1 Vybion, Inc Company Profile and Recent Development

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 WAVE Life Sciences Ltd

    • 11.17.1 WAVE Life Sciences Ltd Company Profile and Recent Development

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 104 Figures and 202 Tables)

  • Figure Product Picture

  • Figure Spinal Muscular Atrophy Medicine Market Size and Growth Rate of LMI-070 from 2014 to 2026

  • Figure Spinal Muscular Atrophy Medicine Market Size and Growth Rate of ND-602 from 2014 to 2026

  • Figure Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NT-1654 from 2014 to 2026

  • Figure Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Nusinersen from 2014 to 2026

  • Figure Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NXD-30001 from 2014 to 2026

  • Figure Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Clinic from 2014 to 2026

  • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Spinal Muscular Atrophy Medicine Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Spinal Muscular Atrophy Medicine

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Spinal Muscular Atrophy Medicine by Different Types from 2014 to 2026

  • Table Consumption Share of Spinal Muscular Atrophy Medicine by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of LMI-070

  • Figure Market Size and Growth Rate of ND-602

  • Figure Market Size and Growth Rate of NT-1654

  • Figure Market Size and Growth Rate of Nusinersen

  • Figure Market Size and Growth Rate of NXD-30001

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Spinal Muscular Atrophy Medicine by Different End-Users from 2014 to 2026

  • Table Consumption Share of Spinal Muscular Atrophy Medicine by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Clinic

  • Figure Market Size and Growth Rate of Others

  • Table Global Spinal Muscular Atrophy Medicine Production by Major Regions

  • Table Global Spinal Muscular Atrophy Medicine Production Share by Major Regions

  • Figure Global Spinal Muscular Atrophy Medicine Production Share by Major Regions in 2014

  • Figure Global Spinal Muscular Atrophy Medicine Production Share by Major Regions in 2018

  • Figure Global Spinal Muscular Atrophy Medicine Production Share by Major Regions in 2026

  • Table Global Spinal Muscular Atrophy Medicine Consumption by Major Regions

  • Table Global Spinal Muscular Atrophy Medicine Consumption Share by Major Regions

  • Figure Global Spinal Muscular Atrophy Medicine Consumption Share by Major Regions in 2014

  • Figure Global Spinal Muscular Atrophy Medicine Consumption Share by Major Regions in 2018

  • Figure Global Spinal Muscular Atrophy Medicine Consumption Share by Major Regions in 2026

  • Table North America Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis

  • Table Europe Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Spinal Muscular Atrophy Medicine market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Spinal Muscular Atrophy Medicine Consumption by Types from 2014 to 2026

  • Table North America Spinal Muscular Atrophy Medicine Consumption Share by Types from 2014 to 2026

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by Types in 2014

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by Types in 2018

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by Types in 2026

  • Table North America Spinal Muscular Atrophy Medicine Consumption by End-Users from 2014 to 2026

  • Table North America Spinal Muscular Atrophy Medicine Consumption Share by End-Users from 2014 to 2026

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2014

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2018

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2026

  • Table North America Spinal Muscular Atrophy Medicine Consumption by Major Countries from 2014 to 2026

  • Table North America Spinal Muscular Atrophy Medicine Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2014

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2018

  • Figure North America Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2026

  • Figure United States Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Spinal Muscular Atrophy Medicine Consumption by Types from 2014 to 2026

  • Table Europe Spinal Muscular Atrophy Medicine Consumption Share by Types from 2014 to 2026

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by Types in 2014

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by Types in 2018

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by Types in 2026

  • Table Europe Spinal Muscular Atrophy Medicine Consumption by End-Users from 2014 to 2026

  • Table Europe Spinal Muscular Atrophy Medicine Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2014

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2018

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2026

  • Table Europe Spinal Muscular Atrophy Medicine Consumption by Major Countries from 2014 to 2026

  • Table Europe Spinal Muscular Atrophy Medicine Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2014

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2018

  • Figure Europe Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2026

  • Figure Germany Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure France Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Spinal Muscular Atrophy Medicine Consumption by Types from 2014 to 2026

  • Table Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Types in 2014

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Types in 2018

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Types in 2026

  • Table Asia Pacific Spinal Muscular Atrophy Medicine Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2014

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2018

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2026

  • Table Asia Pacific Spinal Muscular Atrophy Medicine Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2026

  • Figure China Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandSpinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure India Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Spinal Muscular Atrophy Medicine Consumption Share by Major Countries in 2026

  • Figure GCC Countries Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Spinal Muscular Atrophy Medicine Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Astellas Pharma Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

  • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

  • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

  • Table Product and Service Introduction of Astellas Pharma Inc

  • Table Company Profile and Development Status of AveXis, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AveXis, Inc

  • Figure Sales and Growth Rate Analysis of AveXis, Inc

  • Figure Revenue and Market Share Analysis of AveXis, Inc

  • Table Product and Service Introduction of AveXis, Inc

  • Table Company Profile and Development Status of Bioblast Pharma Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bioblast Pharma Ltd

  • Figure Sales and Growth Rate Analysis of Bioblast Pharma Ltd

  • Figure Revenue and Market Share Analysis of Bioblast Pharma Ltd

  • Table Product and Service Introduction of Bioblast Pharma Ltd

  • Table Company Profile and Development Status of Cytokinetics, Inc 24

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cytokinetics, Inc 24

  • Figure Sales and Growth Rate Analysis of Cytokinetics, Inc 24

  • Figure Revenue and Market Share Analysis of Cytokinetics, Inc 24

  • Table Product and Service Introduction of Cytokinetics, Inc 24

  • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

  • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

  • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

  • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

  • Table Company Profile and Development Status of Genethon

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genethon

  • Figure Sales and Growth Rate Analysis of Genethon

  • Figure Revenue and Market Share Analysis of Genethon

  • Table Product and Service Introduction of Genethon

  • Table Company Profile and Development Status of Genzyme Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme Corporation

  • Figure Sales and Growth Rate Analysis of Genzyme Corporation

  • Figure Revenue and Market Share Analysis of Genzyme Corporation

  • Table Product and Service Introduction of Genzyme Corporation

  • Table Company Profile and Development Status of GMP-Orphan SAS

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GMP-Orphan SAS

  • Figure Sales and Growth Rate Analysis of GMP-Orphan SAS

  • Figure Revenue and Market Share Analysis of GMP-Orphan SAS

  • Table Product and Service Introduction of GMP-Orphan SAS

  • Table Company Profile and Development Status of Ionis Pharmaceuticals, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals, Inc

  • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals, Inc

  • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals, Inc

  • Table Product and Service Introduction of Ionis Pharmaceuticals, Inc

  • Table Company Profile and Development Status of Longevity Biotech, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Longevity Biotech, Inc

  • Figure Sales and Growth Rate Analysis of Longevity Biotech, Inc

  • Figure Revenue and Market Share Analysis of Longevity Biotech, Inc

  • Table Product and Service Introduction of Longevity Biotech, Inc

  • Table Company Profile and Development Status of Neurodyn Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurodyn Inc

  • Figure Sales and Growth Rate Analysis of Neurodyn Inc

  • Figure Revenue and Market Share Analysis of Neurodyn Inc

  • Table Product and Service Introduction of Neurodyn Inc

  • Table Company Profile and Development Status of Neurotune AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurotune AG

  • Figure Sales and Growth Rate Analysis of Neurotune AG

  • Figure Revenue and Market Share Analysis of Neurotune AG

  • Table Product and Service Introduction of Neurotune AG

  • Table Company Profile and Development Status of Novartis AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

  • Figure Sales and Growth Rate Analysis of Novartis AG

  • Figure Revenue and Market Share Analysis of Novartis AG

  • Table Product and Service Introduction of Novartis AG

  • Table Company Profile and Development Status of Sarepta Therapeutics, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sarepta Therapeutics, Inc

  • Figure Sales and Growth Rate Analysis of Sarepta Therapeutics, Inc

  • Figure Revenue and Market Share Analysis of Sarepta Therapeutics, Inc

  • Table Product and Service Introduction of Sarepta Therapeutics, Inc

  • Table Company Profile and Development Status of Voyager Therapeutics, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Voyager Therapeutics, Inc

  • Figure Sales and Growth Rate Analysis of Voyager Therapeutics, Inc

  • Figure Revenue and Market Share Analysis of Voyager Therapeutics, Inc

  • Table Product and Service Introduction of Voyager Therapeutics, Inc

  • Table Company Profile and Development Status of Vybion, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vybion, Inc

  • Figure Sales and Growth Rate Analysis of Vybion, Inc

  • Figure Revenue and Market Share Analysis of Vybion, Inc

  • Table Product and Service Introduction of Vybion, Inc

  • Table Company Profile and Development Status of WAVE Life Sciences Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of WAVE Life Sciences Ltd

  • Figure Sales and Growth Rate Analysis of WAVE Life Sciences Ltd

  • Figure Revenue and Market Share Analysis of WAVE Life Sciences Ltd

  • Table Product and Service Introduction of WAVE Life Sciences Ltd


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top